Primary Breast Lymphoma: A Rare but Important Differential Diagnosis in Patients with Breast Malignancy.

IF 0.7 Q4 ONCOLOGY
South Asian Journal of Cancer Pub Date : 2024-08-29 eCollection Date: 2025-07-01 DOI:10.1055/s-0044-1789604
Irappa Madabhavi, Malay Sarkar, Raghavendra Sagar, Swaroop Revannasiddaiah, Vineet Kumar
{"title":"Primary Breast Lymphoma: A Rare but Important Differential Diagnosis in Patients with Breast Malignancy.","authors":"Irappa Madabhavi, Malay Sarkar, Raghavendra Sagar, Swaroop Revannasiddaiah, Vineet Kumar","doi":"10.1055/s-0044-1789604","DOIUrl":null,"url":null,"abstract":"<p><p>This report is based upon the case of a young lady who presented with a history of a breast lump, which despite clinically resembling a carcinoma, was subsequently diagnosed to be a primary breast lymphoma (PBL). Though rare in incidence, PBL may masquerade as breast carcinoma. PBL accounts for about 1.7-2.2% of all extranodal non-Hodgkin's lymphoma, and is accountable for up to 0.5% of all breast malignancies. Given that the treatments of breast carcinoma and PBL are markedly different, it is very essential that core-biopsy be preferred in every patient being evaluated for carcinoma of the breast. The diagnosis of diffuse large B cell lymphoma (DLBCL) was confirmed by immunohistochemistry, and the patient has been treated with six-cycles of chemotherapy followed by involved field-radiotherapy to the right breast. After a year's follow-up, the patient remains free of disease.</p>","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"14 3","pages":"517-519"},"PeriodicalIF":0.7000,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12727010/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"South Asian Journal of Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0044-1789604","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

This report is based upon the case of a young lady who presented with a history of a breast lump, which despite clinically resembling a carcinoma, was subsequently diagnosed to be a primary breast lymphoma (PBL). Though rare in incidence, PBL may masquerade as breast carcinoma. PBL accounts for about 1.7-2.2% of all extranodal non-Hodgkin's lymphoma, and is accountable for up to 0.5% of all breast malignancies. Given that the treatments of breast carcinoma and PBL are markedly different, it is very essential that core-biopsy be preferred in every patient being evaluated for carcinoma of the breast. The diagnosis of diffuse large B cell lymphoma (DLBCL) was confirmed by immunohistochemistry, and the patient has been treated with six-cycles of chemotherapy followed by involved field-radiotherapy to the right breast. After a year's follow-up, the patient remains free of disease.

Abstract Image

原发性乳腺淋巴瘤:乳腺恶性肿瘤中一种罕见但重要的鉴别诊断。
本报告基于一位年轻女士的病例,她提出了乳房肿块的病史,尽管临床上类似于癌症,但随后被诊断为原发性乳腺淋巴瘤(PBL)。虽然发病率低,PBL可能伪装成乳腺癌。PBL约占所有结外非霍奇金淋巴瘤的1.7-2.2%,占所有乳腺恶性肿瘤的0.5%。考虑到乳腺癌和PBL的治疗方法明显不同,对于每一位被评估为乳腺癌的患者,首选核心活检是非常必要的。经免疫组织化学证实为弥漫性大B细胞淋巴瘤(DLBCL),患者接受了6个周期的化疗,然后在右乳进行了受病灶野放疗。经过一年的随访,病人仍然无病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.00
自引率
0.00%
发文量
80
审稿时长
35 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书